Eli Lilly & Co. (NYSE:LLY)
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
bclan13
(99.31)
Submitted: 1/30/2013 1:43:14 AM :
Start Price:
$53.27
LLY Score:
+8.10
Has to be the worst of breed pharma.
Recs
6sigmaford
(26.72)
Submitted: 11/15/2012 12:02:53 PM :
Start Price:
$44.92
LLY Score:
-1.55
Diabetes will be around a long time and so will Lilly.
Recs
campwt00global
(37.82)
Submitted: 11/4/2012 8:34:04 PM :
Start Price:
$47.03
LLY Score:
-1.83
http://seekingalpha.com/article/976681-steven-cohen-s-10-favorite-dividend-stock-picks
Recs
GVA1
(< 20)
Submitted: 10/14/2012 9:58:32 AM :
Start Price:
$49.49
LLY Score:
-6.02
Surprising success in Alzheimer's portfolio
Recs
TMFBiologyFool
(99.14)
Submitted: 10/12/2012 12:25:24 PM :
Start Price:
$49.10
LLY Score:
+5.50
Over exuberance for Alzheimer's program.
Recs
FoolWithFive
(98.76)
Submitted: 7/25/2012 12:04:25 PM :
Start Price:
$41.74
LLY Score:
+6.16
They are the heart and soul of indianapolis. This company does great things for the state of Indiana and health care!
Recs
WHOVPLLC
(31.99)
Submitted: 7/3/2012 11:20:43 PM :
Start Price:
$41.38
LLY Score:
+10.07
Eli Lilly Company is one of the premier BIG PHARMA companies based in Indianopolis, IN. With the new Obama Health care moving by phases into effect, Health Insurance Coverage will be near Universal in the United States. Demand for Health Services will be fueled by the newly covered population. With Universal coverage, of course comes Government Price Controls.
Many Physicians and other Healthcare providers Opted-out of Medicare in 2011 more will opt-out in 2012. Once a Healthcare provider opts-out they can NOT return and get back-into Medicare or Medicade. They opt-out, of course, to control their own business practice of Medicine. That practice Business decision comes with it a diminished available market.
Sobeit say the providers who opt-out. Let them pound sand will say the patients.
WHOVenturePartners, LLC
Kailua-Kona 96745
Recs
einzling44
(34.68)
Submitted: 5/15/2012 4:04:46 AM :
Start Price:
$39.28
LLY Score:
-14.49
cap spending ahead
Recs
sunvestor7
(< 20)
Submitted: 3/10/2012 5:44:36 PM :
Start Price:
$37.62
LLY Score:
-23.73
A fossilized company that will unfortunately go the way of dinosaurs. They have a major patent gap on them and I do not see how they can overcome with "same old" corporate culture. This one is cooked.
Recs
slih
(< 20)
Submitted: 1/26/2012 12:58:31 AM :
Start Price:
$37.45
LLY Score:
+20.43
veternary products; retained corporate brainpower
Recs
fooluser17
(75.56)
Submitted: 1/19/2012 2:04:19 PM :
Start Price:
$37.69
LLY Score:
+17.94
Dividend rockstar, most numbers are good. Probably make this one 1%.
Recs
jesseangels
(< 20)
Submitted: 1/13/2012 7:41:59 PM :
Start Price:
$37.68
LLY Score:
+16.60
Undervalued. Target ~50$.
Recs
guinness4life
(71.29)
Submitted: 12/21/2011 6:21:56 PM :
Start Price:
$39.19
LLY Score:
+5.51
Long this. Gorgeous value stock with great dividend. I got in a few months ago. Get in the next time a drug misses approval.
Recs
Recs
GETRICHSLOW2
(60.86)
Submitted: 12/12/2011 10:16:26 PM :
Start Price:
$36.64
LLY Score:
+15.37
Falling off the patent cliff but the metrics look outstanding. A great time to buy in. Company has been around since 1901. I doubt they will go under just because of a few patent expirations. Currently yielding 5%. p/e=8.5, payout ratio=43%, beta= 0.67.
Buy Buy Buy!
Recs
Divlover
(35.93)
Submitted: 12/8/2011 4:09:44 PM :
Start Price:
$36.54
LLY Score:
+14.80
Possible Alzhiemer drug in the works and a nice dividend.
Recs
SearchS
(48.50)
Submitted: 12/6/2011 9:27:59 PM :
Start Price:
$36.84
LLY Score:
+15.58
Promising drugs in the pipeline...
Recs
Recs
Ipad
(46.42)
Submitted: 9/22/2011 11:30:14 PM :
Start Price:
$33.71
LLY Score:
+13.80
fundamentals look very goog
Recs
giannelli5
(20.11)
Submitted: 8/11/2011 12:59:01 PM :
Start Price:
$32.37
LLY Score:
+25.12
Good dividend; bought near low
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 195 : 1 2 3 4 5 6 7 8 9 10 Next »